 |
| |
| Sep-14-17 07:30AM | Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire |
| Sep-13-17 08:20AM | Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22% |
| Sep-12-17 07:30AM | Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13% |
| Sep-11-17 08:51PM | Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67% |
| Sep-06-17 09:12AM | Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38% |
| Aug-21-17 10:00AM | AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research |
| Aug-11-17 09:02AM | Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes |
| Aug-10-17 04:15PM | Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56% |
| 01:00PM | Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
| Aug-03-17 07:29PM | ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube |
| 08:00AM | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire |
| Jul-19-17 07:11AM | Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire |
| Jul-07-17 07:00AM | Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire |
| Jul-03-17 02:46PM | ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube |
| Jun-30-17 03:00PM | AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research |
| 12:50PM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube |
| Jun-28-17 04:15PM | Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23% |
| Jun-26-17 08:15AM | Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire |
| Jun-14-17 08:00AM | Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00% |
| Jun-06-17 08:00AM | Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire |
| May-24-17 08:00AM | Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24% |
| Apr-28-17 11:00AM | AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research |
| Apr-24-17 09:25AM | Aethlon Medical Releases Shareholder Update PR Newswire |
| Apr-04-17 09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire -19.47% |
| 09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio |
| Mar-31-17 09:17AM | AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of |
| Mar-21-17 02:50PM | AETHLON MEDICAL INC Files SEC form 8-K, Other Events |
| Mar-14-17 05:17PM | AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.59% |
| Mar-13-17 07:15AM | Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire +31.74% |
| Mar-08-17 09:25AM | Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire |
| Mar-01-17 09:25AM | Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire |
| Feb-24-17 09:25AM | Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire |
| Feb-22-17 09:25AM | Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire |
| Feb-16-17 01:04PM | AETHLON MEDICAL INC Financials |
| Feb-15-17 09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research |
| 09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway |
| Feb-10-17 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report -9.62% |
| 04:15PM | Aethlon Medical Announces Fiscal 2017 Third Quarter Results PR Newswire |
| 07:07AM | Q3 2017 Aethlon Medical Inc Earnings Release - After Market Close |
| Feb-07-17 04:16PM | AETHLON MEDICAL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar |
| Feb-06-17 09:25AM | Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017 PR Newswire |
| Jan-27-17 11:00AM | AEMD: New CTE Study Largest in Ex-NFL Players |
| Jan-25-17 09:41AM | Aethlon Medical Inc. (AEMD) Readies CTE Blood Diagnostic Trial As Super Bowl LI Approaches at Insider Monkey |
| 07:00AM | Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players PR Newswire |
| Jan-20-17 12:43PM | ETFs with exposure to Aethlon Medical, Inc. : January 20, 2017 |
| Jan-11-17 09:12AM | CEO Note - Clinical Study Update and a Review of 2016 Accomplishments PR Newswire |
| Jan-03-17 12:21PM | ETFs with exposure to Aethlon Medical, Inc. : January 3, 2017 |
| Dec-30-16 03:06PM | AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob |
| Dec-22-16 12:46PM | ETFs with exposure to Aethlon Medical, Inc. : December 22, 2016 |
| Dec-21-16 09:25AM | Passage of the 21st Century Cures Act and its Potential Implications on Biodefense PR Newswire |
| Dec-15-16 09:25AM | Aethlon Announces Initiation of Sepsis-Related Virus Study PR Newswire |
| Dec-08-16 02:09PM | ETFs with exposure to Aethlon Medical, Inc. : December 8, 2016 |
| Nov-16-16 12:33PM | ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016 -9.00% |
| Nov-14-16 11:52AM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016 |
| Nov-10-16 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report |
| 04:15PM | Aethlon Medical Announces Fiscal 2017 Second Quarter Results PR Newswire |
| 07:07AM | Q2 2017 Aethlon Medical Inc Earnings Release - After Market Close |
| Nov-03-16 09:25AM | Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016 PR Newswire |
| Nov-01-16 01:21PM | Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial at Insider Monkey |
| Oct-13-16 09:11AM | Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation PR Newswire |
| Oct-12-16 09:25AM | Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum PR Newswire |
| Sep-20-16 09:25AM | Aethlon Medical Updates Corporate Presentation Schedule PR Newswire |
| Sep-12-16 09:25AM | Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016 PR Newswire |
| Sep-09-16 09:09AM | The Dilemma in Funding Zika and Other Pandemic Therapies PR Newswire |
| Sep-06-16 09:25AM | Aethlon Medical Announces Upcoming September Investor And Industry Conferences PR Newswire |
| Aug-22-16 12:20PM | Edited Transcript of AEMD earnings conference call or presentation 11-Aug-16 8:30pm GMT |
| Aug-18-16 10:20AM | AEMD: Q1 Results. Add Zika to List of Potential Targets -10.83% |
| Aug-11-16 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report +23.40% |
| 04:15PM | Aethlon Medical Announces Fiscal 2017 First Quarter Results PR Newswire |
| 01:05PM | 5 Biohealth Stocks Rising 10% or More on News at 24/7 Wall St. |
| 09:12AM | Aethlon Medical Announces Zika Virus Data PR Newswire |
| 07:07AM | Q1 2017 Aethlon Medical Inc Earnings Release - Time Not Supplied |
| Aug-10-16 03:02PM | AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal |
| Aug-09-16 12:07PM | Aethlon Medical To Host First Quarter Fiscal 2017 Investor Call On August 11, 2016 PR Newswire |
| Jul-26-16 09:27AM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 |
| Jul-20-16 12:06PM | ETFs with exposure to Aethlon Medical, Inc. : July 20, 2016 |
| Jul-06-16 10:11AM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016 |
| Jul-05-16 09:45AM | AEMD: U.S. Clinical Trial Progressing, ATM Financing |
| Jun-30-16 11:44AM | Edited Transcript of AEMD earnings conference call or presentation 29-Jun-16 8:30pm GMT |
| Jun-29-16 05:18PM | AETHLON MEDICAL INC Files SEC form 10-K, Annual Report +6.79% |
| 04:15PM | Aethlon Medical Announces Fiscal 2016 Results PR Newswire |
| 07:07AM | Q4 2016 Aethlon Medical Inc Earnings Release - Time Not Supplied |
| Jun-28-16 09:15AM | Aethlon Medical Announces $12.5 Million At The Market Program PR Newswire |
| 08:16AM | AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur |
| Jun-27-16 09:45AM | Aethlon Medical Joins Russell Microcap® Index PR Newswire |
| 09:15AM | Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016 PR Newswire |
| Jun-22-16 09:15AM | Aethlon Medical Set To Join Russell Microcap® Index PR Newswire +6.70% |
| Jun-14-16 10:28AM | Aethlon Medical Announces Issuance Of Exosome Capture Patent PR Newswire +10.02% |
| Jun-07-16 02:04PM | AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| Jun-06-16 09:30AM | Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention PR Newswire +8.21% |
| Jun-03-16 02:04PM | AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| Jun-01-16 09:30AM | Aethlon Medical To Present At 2nd Annual Sachs Associates Immuno-oncology: BD&L And Investment Forum On June 3, 2016 PR Newswire |
| May-25-16 04:00PM | AEMD: U.S. Study Progressing. Zika May Offer Another Opportunity |
| May-19-16 08:45AM | 4 Companies That May Benefit From the Rio Olympic Games at 24/7 Wall St. |
| May-05-16 09:00AM | Aethlon Medical's CEO and Executive Chairman James Joyce Interviewed by The Life Sciences Report Marketwired |
| May-04-16 09:30AM | Aethlon Medical's Exosome Sciences Announces Production of ELLSA Exosome Isolation Platform PR Newswire |
| May-02-16 08:45AM | Aethlon Medical (AEMD) CEO Note: Hemopurifier Clinical Progression, USA Today on the Next Zika, Combating Bioterror & Pandemic Threats PR Newswire +6.17% |
| Apr-05-16 09:00AM | FinancialBuzz.com Exclusive NASDAQ MarketSite Interview with Aethlon Medical, Inc. CEO James Joyce PR Newswire |
| Mar-31-16 09:30AM | Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements PR Newswire |
| Mar-30-16 06:09PM | AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of +5.14% |
|
|
|
|
| Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Champion Christopher O | SVP, CAO and Controller | Jun 01 | Option Exercise | 0.00 | 1,491 | 0 | 4,267 | Jun 05 04:23 PM | | CHASE ANTHONY R | Director | May 18 | Buy | 52.48 | 1,905 | 99,967 | 23,636 | May 18 04:27 PM | | WALKER R A | Chairman, President & CEO | May 17 | Buy | 51.82 | 19,300 | 1,000,213 | 176,718 | May 17 05:25 PM | | FLUOR PETER J | Director | May 17 | Buy | 51.83 | 20,000 | 1,036,556 | 146,750 | May 17 05:22 PM | | GORDON JOHN R | Director | May 11 | Option Exercise | 47.20 | 3,950 | 186,440 | 180,375 | May 12 04:37 PM | | Hollek Darrell E | EVP, Operations | Apr 27 | Option Exercise | 0.00 | 25,762 | 0 | 40,723 | May 01 05:33 PM | | GORDON JOHN R | Director | Nov 11 | Sale | 61.30 | 7,500 | 459,750 | 171,079 | Nov 15 04:54 PM | | GORDON JOHN R | Director | Nov 10 | Option Exercise | 47.97 | 7,500 | 359,775 | 178,579 | Nov 15 04:54 PM | | WALKER R A | Chairman, President & CEO | Nov 06 | Option Exercise | 0.00 | 19,820 | 0 | 161,545 | Nov 07 06:14 PM | | Hollek Darrell E | EVP, U.S. Onshore Expl./Prod. | Nov 06 | Option Exercise | 0.00 | 3,146 | 0 | 15,375 | Nov 07 06:13 PM | | GWIN ROBERT G | EVP, Finance & CFO | Nov 06 | Option Exercise | 0.00 | 7,912 | 0 | 112,617 | Nov 07 06:10 PM | | DANIELS ROBERT P | EVP | Nov 06 | Option Exercise | 0.00 | 8,091 | 0 | 41,339 | Nov 07 06:08 PM | | REEVES ROBERT K | EVP, Law & CAO | Nov 06 | Option Exercise | 0.00 | 6,193 | 0 | 115,530 | Nov 07 06:06 PM | | Leyendecker Ernest A. III | EVP, Intl./Deepwater Expl. | Nov 06 | Option Exercise | 0.00 | 2,605 | 0 | 17,806 | Nov 07 06:04 PM | | Ingram Mitchell W | EVP, Global LNG | Nov 01 | Option Exercise | 0.00 | 19,937 | 0 | 20,030 | Nov 02 05:06 PM | | WALKER R A | Chairman, President & CEO | Oct 26 | Option Exercise | 0.00 | 13,403 | 0 | 151,220 | Oct 27 07:32 PM | | Leyendecker Ernest A. III | EVP, Intl./Deepwater Expl. | Oct 26 | Option Exercise | 0.00 | 1,933 | 0 | 16,023 | Oct 27 07:29 PM | | DANIELS ROBERT P | EVP | Oct 26 | Option Exercise | 0.00 | 5,496 | 0 | 37,133 | Oct 27 07:26 PM | | GWIN ROBERT G | EVP, Finance & CFO | Oct 26 | Option Exercise | 0.00 | 5,375 | 0 | 108,503 | Oct 27 07:24 PM | | Champion Christopher O | VP, CAO and Controller | Oct 26 | Option Exercise | 0.00 | 1,691 | 0 | 3,212 | Oct 27 07:21 PM | | REEVES ROBERT K | EVP, Law & CAO | Oct 26 | Option Exercise | 0.00 | 4,191 | 0 | 112,303 | Oct 27 07:18 PM |
|
|
|
|
|
|
